article thumbnail

Does It Really Matter How the COVID-19 Pandemic Started?

Bill of Health

By Barbara Pfeffer Billauer Throughout the COVID-19 pandemic, much air time and social media space has been allocated to the lab leak vs. natural spillover dispute regarding the origins of SARS-CoV-2. Debating the origins of the COVID-19 pandemic is a fool’s errand. Generally, COVID-19 specimens are handled in BSL-3 labs.

COVID-19 284
article thumbnail

COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues

Bill of Health

Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. government committed more than one billion dollars to Moderna for development of its COVID-19 vaccines. By Aparajita Lath.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Covid-19 Can Inspire Tech-Enabled Value-Based Health Care in a Cash-Constrained America

Health Populi

“The COVID-19 pandemic…has highlighted like never before the pitfalls of paying for healthcare based on the number of patients seen and services rendered,” a Modern Healthcare article asserted in mid-June 2020. The COVID-19 pandemic has also taught clinicians and health care administrators about the value of data at the ready.

COVID-19 106
article thumbnail

Using Legal Preparedness to Minimize Liability Barriers to Accessing Pandemic Vaccine and Medical Countermeasures

Bill of Health

The COVID-19 pandemic has amplified this legal challenge and highlighted the need to treat liability as a key legal preparedness issue. The demand for liability protections reemerged in 2009 during H1N1, in attenuated form during the 2014-15 West Africa Ebola public health emergency, and, prominently, during COVID-19.

COVID-19 201
article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

COVID-19 antivirals must not affect HIV drug supply. Anticancer Drugs Approved by the US Food and Drug Administration From 2009 to 2020 According to Their Mechanism of Action. A full posting of abstracts/summaries of these articles may be found on our? Barber M, Sarpatwari A, Cepuch C. Lancet HIV. 2021 Dec 8. JAMA Netw Open.

COVID-19 176
article thumbnail

Biosafety Labs, Public Safety, and Politics

Bill of Health

By Barbara Pfeffer Billauer On May 25, 2023 , merely six weeks before the Wuhan Biosafety lab lost its NIH funding amid the controversy of possible lab leaks and connection with COVID-19, the United States proudly opened the doors of the National Bio and Agro-Defense Facility (NBAF), the 14th biosafety level 4 lab in the U.S.,

article thumbnail

Americans’ Sense of Well-Being Falls to Great Recession Levels, Gallup Finds

Health Populi

As COVID-19 diagnoses reached 200,000 in the U.S. ” Health Populi’s Hot Points: To further inform insights from the Gallup poll, I looked at a study From GfK on Navigating COVID-19, exploring changing consumers. in April 2020, Gallup gauged that barely 1 in 2 people felt they were thriving.

COVID-19 174